{"id":17679,"date":"2014-02-24T03:30:00","date_gmt":"2014-02-24T02:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/soros-scommette-sul-crollo-di-wallstreet\/"},"modified":"2014-02-24T03:30:00","modified_gmt":"2014-02-24T02:30:00","slug":"soros-scommette-sul-crollo-di-wallstreet","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/soros-scommette-sul-crollo-di-wallstreet\/","title":{"rendered":"Soros bets on the collapse of WallStreet"},"content":{"rendered":"<p style=\"text-align: left\"><span id=\"result_box\" lang=\"it\"><span style=\"font-size: xx-large\"><strong>EU fines: 93 million and 800 thousand euros for LUNDBECK<\/strong><\/span><br \/> <span style=\"font-family: Verdana\"><br \/> <span style=\"font-size: medium\"><span class=\"hps\">The European Commission has<\/span> <span class=\"hps\">fined<\/span> <span class=\"hps\">the Danish pharmaceutical company<\/span> <span class=\"hps\">Lundbeck<\/span> For <span class=\"hps\">\u20ac93,800,000<\/span> <span class=\"hps\">After<\/span> That <span class=\"hps\">the EU executive<\/span> <span class=\"hps\">established that<\/span> <span class=\"hps\">had paid<\/span> <span class=\"hps\">rival companies<\/span> <span class=\"hps\">to delay<\/span> <span class=\"hps\">market entry<\/span> <span class=\"hps\">of versions <\/span><\/span><\/span><span style=\"font-size: medium\"><span class=\"hps\">generic of<\/span><span class=\"hps\">antidepressant<\/span> <span class=\"hps\">Citalopram<\/span>.<\/span><\/span><\/p>\n<p style=\"text-align: left\"><span lang=\"it\"><span style=\"font-size: medium\">source<\/span><\/span><span style=\"font-size: large\"><span lang=\"it\">:<\/span><\/span><span style=\"font-size: medium\">http:\/\/euobserver.com\/tickers\/120551?<\/span>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><span lang=\"EN-US\" style=\"line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: #c00000; font-size: 18pt; font-weight: normal; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-ansi-language: EN-US; mso-font-kerning: 18.0pt\">CORRECTED-UPDATE 2-EU fines Lundbeck and others 146 mln euros for blocking rival drugs<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><span class=\"timestamp128\"><font color=\"#666666\"><span style=\"line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; font-size: 8.5pt\">Wed Jun 19, 2013 9:16am EDT<\/span><\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 7.5pt\"><span lang=\"EN-US\" style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; font-size: 10.5pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-ansi-language: EN-US\">By <\/span><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; font-size: 10.5pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\"><a href=\"http:\/\/blogs.reuters.com\/search\/journalist.php?edition=us&amp;n=Foo.Yun\" target=\"_blank\" rel=\"noopener\"><span lang=\"EN-US\" style=\"color: #006e97; text-decoration: none; text-underline: none; mso-ansi-language: EN-US\">Foo Yun<\/span><\/a><\/span><span lang=\"EN-US\" style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; font-size: 10.5pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-ansi-language: EN-US\"> Which is<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 7.5pt\"><font size=\"3\"><span lang=\"EN-US\" style=\"display: none; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-ansi-language: EN-US; mso-hide: all\">BRUSSELS, June 19<\/span><span lang=\"EN-US\" style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-ansi-language: EN-US\"> (Reuters) \u2013 European antitrust regulators fined nine drugmakers, including Denmark&#039;s Lundbeck, a total of 146 million euros ($195 million) for blocking the supply of a cheaper anti-depressant to the market, the first EU sanction against such deals.<\/p>\n<p><\/span><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 7.5pt\"><span lang=\"EN-US\" style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-ansi-language: EN-US\"><font size=\"3\">The punishments follow a 2009 report by the European Commission on the pharmaceutical sector, which said &quot;pay-for-de<\/p>","protected":false},"excerpt":{"rendered":"<p>Multe UE: alla LUNDBECK 93 milioni e 800 mila euro La Commissione europea ha multato l&#8217;Azienda farmaceutica danese Lundbeck per &euro; 93.800.000 dopo che l&#8217;esecutivo Ue ha stabilito che aveva pagato aziende rivali di ritardare l&#8217;ingresso sul mercato di versioni generiche dell&#8217;antidepressivo Citalopram. fonte:http:\/\/euobserver.com\/tickers\/120551?&nbsp; &nbsp; CORRECTED-UPDATE 2-EU fines Lundbeck and others 146 mln euros for &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-17679","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17679","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=17679"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17679\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=17679"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=17679"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=17679"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}